Does Medicare Cover Weight Loss Drugs Like Ozempic and Wegovy?
Yes, Medicare coverage for certain weight loss drugs became more nuanced in July 2026. Under the temporary Medicare GLP-1 Bridge, eligible adults with Medicare Part D may receive certain GLP-1 medications for weight management for a fixed $50 copayment per one-month supply.
The Bridge is not the same as standard Medicare Part D coverage. Historically, Part D generally has not covered drugs used purely for weight loss or weight gain. The Bridge creates a limited, time-sensitive pathway for some people who meet specific coverage, health, and BMI requirements. It runs from July 1, 2026, through December 31, 2027.
Your eligibility depends on your Medicare drug coverage, medical history, current prescriptions, and the drug formulation prescribed. Program details can change, so it is important to confirm the current rules through Medicare’s official weight loss drugs page.
The Short Answer About Ozempic, Wegovy, And Other GLP-1 Drugs
Wegovy may be covered through the Medicare GLP-1 Bridge if you qualify. The Bridge currently covers:
- Wegovy, all formulations
- Foundayo, all formulations
- Zepbound KwikPen only
The Bridge does not cover Zepbound single-dose pens or vials.
Ozempic is not listed among the drugs covered through the Bridge. Medicare generally does not cover a drug when it is prescribed purely for weight loss under the standard Part D benefit. However, a Part D plan may cover a GLP-1 drug for an FDA-approved medical indication other than weight loss, depending on the drug, your plan, and its coverage requirements.
That distinction is important. A weight management prescription may follow the temporary Bridge pathway. A prescription for a covered medical condition may instead be reviewed through your own Part D plan.
What Medicare DOES Cover
The Medicare GLP-1 Bridge
The Medicare GLP-1 Bridge is a CMS demonstration program for certain Medicare beneficiaries who have Part D drug coverage. Eligible coverage may include a standalone Part D plan or a Medicare Advantage plan that includes prescription drug coverage.
Under the Bridge, the cost is generally:
- $50 for a one-month supply
- A fixed copayment regardless of the covered dose
- A payment that does not count toward your Part D deductible
- A payment that does not count toward your annual Part D out-of-pocket limit
- A payment that cannot be spread across multiple months through the Medicare Prescription Payment Plan
The $50 copayment is separate from your standard Part D costs. It may not appear in the same way as regular Part D expenses on your plan documents.
The Bridge is temporary. It is scheduled to continue through December 31, 2027. CMS may publish updates to the program, covered drugs, or eligibility requirements.
Eligibility Requirements
Eligibility is specific. Generally, you must meet all of the following requirements:
- You are at least 18 years old.
- You have eligible Medicare Part D drug coverage.
- You are not already able to receive a GLP-1 drug through your existing Part D plan.
- You are not already receiving a GLP-1 drug through another Medicare drug plan.
- You do not have or receive treatment for type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease known as MASH.
- You meet the applicable BMI and health criteria.
- A healthcare provider prescribes a covered GLP-1 drug and completes the required prior authorization process.
The BMI criteria generally include one of these pathways:
- A BMI of 35 or higher
- A BMI of 30 or higher with a qualifying condition, such as certain heart failure, uncontrolled high blood pressure, or stage 3a or higher chronic kidney disease
- A BMI of 27 or higher with a qualifying history or condition, such as prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease
These criteria are summarized for general education. The exact requirements, definitions, and documentation must be confirmed through Medicare.gov and your healthcare provider.
Having type 2 diabetes, sleep apnea, or MASH does not mean you are being left without options. These conditions may allow a GLP-1 drug to be reviewed through your regular Part D coverage instead of the Bridge. The Bridge is not the right pathway because those medical indications may already be handled differently under Medicare drug coverage.
How The Bridge Works
If you may qualify, the process generally includes these steps:
- You discuss your health history and treatment options with your healthcare provider.
- Your provider determines whether a covered GLP-1 drug may be appropriate.
- Your provider sends the prescription to the pharmacy.
- Your provider submits the required prior authorization information when requested.
- Medicare sends you a notice when the medication is approved through the Bridge.
- You pay the applicable $50 copayment for a one-month supply.
Approval generally remains valid through December 31, 2027, including refills and dose changes, unless you switch to a different GLP-1 drug. Your provider must also certify that the medication is being used as part of a lifestyle program focused on diet and physical activity.
What Medicare Does NOT Cover
Standard Part D Coverage For Weight Loss Alone
Standard Medicare Part D rules generally exclude drugs used purely for weight loss or weight gain. This remains the basic rule outside the Medicare GLP-1 Bridge.
A drug may be prescribed for weight management, but that prescription does not automatically create Part D coverage. Your plan may review the purpose of the prescription, the medication, and whether the indication is covered.
Every GLP-1 Drug Or Formulation
The Bridge does not cover every GLP-1 drug or every form of a covered drug.
Currently, the Bridge covers Wegovy and Foundayo in the formulations described by Medicare, along with Zepbound KwikPen. It does not cover Zepbound single-dose pens or vials.
Do not assume that a prescription is covered simply because it belongs to the same general medication category. The exact product and formulation matter.
Bridge Coverage When Your Part D Plan Already Covers The Drug
The Bridge is intended for people who cannot already receive a GLP-1 drug through their existing Part D coverage. If you are already receiving a GLP-1 through a Medicare drug plan, you generally must continue using that plan’s coverage pathway instead of the Bridge.
Your plan may have its own formulary, prior authorization, or other requirements. A review of your current prescription drug coverage can help clarify which pathway applies.
Bridge Payments Toward Your Part D Limits
The Bridge’s $50 copayment does not count toward your Part D deductible or annual out-of-pocket limit. It also does not qualify for the Medicare Prescription Payment Plan.
This is one of the most important cost details to understand before filling a prescription. The $50 payment is a Bridge copayment, not a standard Part D expense.
Why Your Medicare Plan Still Matters
The Medicare GLP-1 Bridge is a federal program, but your overall prescription coverage still matters. Your plan may cover certain medications for a medical indication such as type 2 diabetes, moderate-to-severe sleep apnea, or MASH. Coverage may depend on your plan’s formulary and prior authorization rules.
During Medicare’s Annual Enrollment Period, from October 15 through December 7, it may be helpful to review your prescription coverage for the upcoming year. You can compare your medications, plan rules, pharmacy choices, and estimated costs. Our guide to Medicare Part D changes for 2027 can provide additional context.
You can also learn more about Medicare prescription drug plans, Medicare Advantage, and Medicare Supplements. Each type of coverage works differently, and the right choice depends on your doctors, prescriptions, budget, and health needs.
Frequently Asked Questions
Does Medicare Cover Ozempic Or Wegovy?
Wegovy may be covered through the Medicare GLP-1 Bridge if you meet the program’s requirements. Ozempic is not listed among the current Bridge-covered drugs. Standard Part D generally does not cover medications prescribed purely for weight loss, although a Part D plan may cover a GLP-1 drug for another FDA-approved medical indication.
Is Wegovy Covered By Medicare Now?
Wegovy may be covered for eligible Part D enrollees through the temporary Medicare GLP-1 Bridge. The current Bridge copayment is $50 for a one-month supply. You must meet the program’s age, coverage, health, BMI, and prior authorization requirements.
What Is The Medicare GLP-1 Bridge?
The Medicare GLP-1 Bridge is a temporary CMS program that provides eligible Medicare Part D beneficiaries access to certain GLP-1 drugs for weight management. It began July 1, 2026, and is scheduled to end December 31, 2027.
How Much Do GLP-1 Drugs Cost With Medicare?
For an eligible person using a covered drug through the Bridge, the copayment is generally $50 for a one-month supply. This amount does not count toward the Part D deductible or annual out-of-pocket limit and cannot be placed in the Medicare Prescription Payment Plan.
Who Qualifies For The $50 GLP-1 Program?
Generally, adults age 18 or older with eligible Part D coverage may qualify if they meet the program’s BMI and health criteria, are not already receiving a covered GLP-1 through Part D, and do not have type 2 diabetes, moderate-to-severe sleep apnea, or MASH. A provider must prescribe the medication and complete the required authorization process.
What If I Have Type 2 Diabetes Or Sleep Apnea?
You may not qualify for the Bridge, but you may have another coverage pathway. Your Part D plan may cover a GLP-1 drug for a qualifying medical indication, subject to that plan’s rules. Ask your provider and plan to review your options.
Does The $50 Count Toward My Deductible Or Out-Of-Pocket Cap?
No. The Bridge copayment generally does not count toward your Part D deductible or annual out-of-pocket limit. It also cannot be spread across several months through the Medicare Prescription Payment Plan.
How Do I Find Out If I Qualify?
Review the current eligibility information on Medicare.gov, talk with your healthcare provider, and confirm your current Part D coverage. A provider must submit the required prescription and prior authorization information.
What Happens When The Program Ends?
The Medicare GLP-1 Bridge is scheduled to end December 31, 2027. Do not assume the program is permanent. CMS will publish any future changes, extensions, or replacement rules. It is best to review current information rather than rely on predictions about what may happen afterward.
Get Help Reviewing Your Prescription Coverage
Medicare coverage for weight loss drugs now depends on more than a simple yes or no. The answer may change based on the medication, formulation, reason for treatment, Part D plan, health history, and eligibility for the temporary GLP-1 Bridge.
Neuse Consulting Group can help you review your specific prescription situation in a calm, educational conversation. We take the time to compare your medications and coverage details so you can better understand what may fit.
Call 984-237-3347 to request a free conversation. You can also visit us at 1956 S. Main St, Wake Forest, NC 27587.
Neuse Consulting Group is based in Wake Forest, North Carolina, and is licensed in 14 states: NC, SC, VA, NJ, WV, PA, NY, TN, GA, FL, OH, AZ, MI, and WI.